Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
21 2월 2025 - 2:18AM
UK Regulatory
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
Christoph Baldegger, primary insider and member of the Board of
Directors in Hofseth BioCare ASA ("HBC") holds 1,500,000 shares
personally and has held 1,747,976 shares indirectly through the
Bonafide fund. Redemption of the fund has led to transfer of his
indirect holdings to his personal account, and hence Mr. Baldegger
now personally holds 3,247,976 shares and zero indirect ownership
in HBC, equal to approximately 0.82 % of the total outstanding
A-shares with voting rights.
For further information, contact:
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements in
the Market Abuse Regulation EU 596/2014 article 19 number 3 and the
Norwegian Securities Trading Act section 5-12.
Hofseth Biocare Asa (LSE:0Q6H)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Hofseth Biocare Asa (LSE:0Q6H)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
